| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-14 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.26 | 1e-12 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-09 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.31 | 1e-08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-08 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-08 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-07 |